Page 5 - Read Online
P. 5
www.cdrjournal.com
Special Issue
Papers from the BACR Conference-Response
and Resistance in Cancer Therapy
Guest Editor(s): Special Issue Introduction
Dr. Tim Fenton This Special Issue will consist of A Selection of Papers from BACR
School of Biosciences, Conference---Response and Resistance in Cancer Therapy
University of Kent, Canterbury (https://www.bacr.org.uk/events/166), held in University of Kent, Canterbury, UK,
CT2 7NJ, UK. on 10th–12th September 2018. Despite substantial improvements in recent
E-Mail: T.Fenton@kent.ac.uk decades, the prognosis for those cancer patients who suffer from metastatic
disease and depend on systemic drug therapy remains poor. Both intrinsic
Prof. Michelle Garrett resistance and the formation of acquired drug resistance substantially affects
School of Biosciences, the efficacy of cancer drugs. The advancement of precision medicine
University of Kent, Canterbury approaches holds promise for both the effective guidance of therapies to
CT2 7NJ, UK. patients that will respond and the ability to monitor this tumour response. This will
E-Mail: M.D.Garrett@kent.ac.uk require the successful interpretation of ‘omics’ data and a close collaboration
between pre-clinical researchers, clinicians, and computational biologists in
Prof. Martin Michaelis both academia and industry to develop these strategies. This conference will
School of Biosciences, bring together and showcase cancer researchers from these areas, who will
University of Kent, Canterbury present and discuss the latest advances in understanding the mechanisms of
CT2 7NJ, UK. drug resistance in cancer, the identification of biomarkers of drug
E-Mail: M.Michaelis@kent.ac.uk sensitivity/resistance and how they can be linked to precision medicine
approaches. This Special Issue will cover new and novel areas of research
Dr. Mark Wass pertaining to Cancer Drug Resistance presented at this conference and
School of Biosciences, therefore will represent state-of-the-art and up-to-date coverage of progress.
University of Kent, Canterbury
CT2 7NJ, UK.
E-Mail: M.N.Wass@kent.ac.uk
Benefits
Rigorous peer review: one manuscript must be reviewed by at least two
experts in this field. We will ensure high standards for the review process and
subsequent publication by a team of efficient and professional reviewers and
scientific editors.
No publication fee: there would be absolutely no charge for publication.
Rapid publication: we will ensure that accepted papers will be published in a
short processing time (the average processing time: 61 days) with a high
quality.
Open access: As an author you will retain the copyright to your work. By
licensing your work under the Creative Commons Attribution License, articles
can be re-used and re-distributed without restriction, as long as the original
work is correctly cited.
Wide promotion: Published articles will be promoted at academic
conferences, through social networks for scientists and relevant indexing
services.
245 E Main Street ste122, Alhambra, CA 91801, USAĠ www.cdrjournal.com/
Telğ+1 323 9987086ĠE-mailğinfo@oaepublish.com journal/special_issues
